Therapy News and Research

RSS

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer, increasing progression-free survival.

26 Sep 2019

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.

26 Sep 2019

Texas Biomed scientists continue testing therapies and vaccines for Ebola virus

In mid-August 2019, human clinical trials were halted in the current Ebola epidemic that has claimed more than 2,100 lives in Africa.

26 Sep 2019

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient's post-operative prostate-specific antigen (PSA) level.

26 Sep 2019

New NIH program aims to improve lives for people with inherited blood and immune diseases

People with inherited diseases of the blood and immune system can now receive treatment at the National Institutes of Health Clinical Center through a new, streamlined program that integrates expertise from many medical specialties and related basic science disciplines.

26 Sep 2019

NIH awards $945 million through NIH HEAL Initiative to reverse opioid crisis

To reverse the opioid crisis that continues to grip the nation, the National Institutes of Health has awarded $945 million in total fiscal year 2019 funding for grants, contracts and cooperative agreements across 41 states through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative.

26 Sep 2019

'A new era of drug discovery’: Company develops drug using AI

For the first time, a company has discovered a drug target and corresponding candidate using artificial intelligence (AI).

26 Sep 2019

Prostate cancer risk linked to assisted reproduction techniques

A study published in BMJ has revealed a link between the risk of prostate cancer and men who have become fathers via assisted reproduction techniques.

26 Sep 2019

Personal Genome Diagnostics applies CE mark to PGDx elio tissue complete assay

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced that it has applied the CE mark to the PGDx elio™ tissue complete assay.

26 Sep 2019

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer (NSCLC) and kidney cancer.

26 Sep 2019

Late-breaking TAILORx data to be presented at ESMO Congress 2019

New data from TAILORx, the federally funded, phase three clinical trial, will be presented as late-breaking information at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.

26 Sep 2019

Scientists use new single-cell genetic technique to tackle potential drug resistance

Using a new technique that can identify genetic profiles of individual cells, University of Notre Dame researchers modeled a breast cancer tumor's potential resistance to a drug, and then identified a drug combination that reversed that resistance.

25 Sep 2019

Experimental treatment shows early promise to help nearly half of DMD patients

A new therapeutic being tested by University of Alberta researchers is showing early promise as a more effective treatment that could help nearly half of patients with Duchenne muscular dystrophy.

25 Sep 2019

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Like catching two fish with one worm, treating two problems with a single drug is efficient, but exceedingly difficult.

25 Sep 2019

Dormant HIV reservoirs could be killed with RNA switch

Researchers from the University of California San Diego School of Medicine have found cellular triggers within the immune cells that could be controlled in order to kill dormant HIV-1 reservoirs in individuals with HIV-1.

25 Sep 2019

Metformin for diabetics with renal damage scores over Sulphonylureas in terms of heart safety

There are several drugs that are being used for treatment of type 2 diabetes. Many type 2 diabetics suffer from kidney disorders that are caused by persistent high levels of blood sugar.

25 Sep 2019

UCLA researchers identify new drug delivery pathway to stop tumor growth

Researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor growth and keep cancer from coming back in mice.

25 Sep 2019

Teenagers sleep 43 more minutes each night after intervention that reset their body clocks

Teenagers got 43 more minutes of sleep a night after a four-week intervention that reset their body clocks and helped them go to bed earlier, a study from the Stanford University School of Medicine has shown.

25 Sep 2019

New review provides knowledge about sex-related differences in Parkinson's disease

There is growing evidence that Parkinson's disease affects women and men differently. In this insightful review, published in the Journal of Parkinson's Disease, scientists present the most recent knowledge about these sex-related differences and highlight the significance of estrogens, which play an important role in the sex differences in PD.

25 Sep 2019

AGS patients more likely to suffer from sexual dysfunction, shows study

AdrenoGenital Syndrome (AGS) encompasses a group of inherited metabolic disorders caused by a disruption in steroid hormone production in the adrenal cortex.

25 Sep 2019

Therapy News and Research

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Texas Biomed scientists continue testing therapies and vaccines for Ebola virus

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

New NIH program aims to improve lives for people with inherited blood and immune diseases

NIH awards $945 million through NIH HEAL Initiative to reverse opioid crisis

'A new era of drug discovery’: Company develops drug using AI

Prostate cancer risk linked to assisted reproduction techniques

Personal Genome Diagnostics applies CE mark to PGDx elio tissue complete assay

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Late-breaking TAILORx data to be presented at ESMO Congress 2019

Scientists use new single-cell genetic technique to tackle potential drug resistance

Experimental treatment shows early promise to help nearly half of DMD patients

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Dormant HIV reservoirs could be killed with RNA switch

Metformin for diabetics with renal damage scores over Sulphonylureas in terms of heart safety

UCLA researchers identify new drug delivery pathway to stop tumor growth

Teenagers sleep 43 more minutes each night after intervention that reset their body clocks

New review provides knowledge about sex-related differences in Parkinson's disease

AGS patients more likely to suffer from sexual dysfunction, shows study

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News